Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • November
  • 16
  • Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India
  • Pharma News

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

Pharm'Up 2 min read

A new Advocacy Paper, developed by leading nephrology experts, outlines a strategic roadmap to overcome the barriers to equitable kidney failure treatment in India, particularly for patients in rural and low-income settings. The focus is on scaling peritoneal dialysis (PD), a simple, life-saving, home-based therapy.

The Emergency and the Equity Gap

India faces a severe kidney failure emergency, with millions requiring dialysis. While public funding schemes have increased access to center-based haemodialysis (HD), this modality presents significant barriers:

  • Travel Burden: Patients must travel to centers 2-3 times a week, heavily disadvantaging those in rural and geographically isolated areas.
  • Capacity Limitation: Availability is constrained by the limited number of dialysis machines at each center.
  • Low PD Uptake: Currently, only 5% of all dialysis patients in India utilize the home-based PD therapy.

PD, which uses the lining of the abdomen (peritoneum) to filter blood, offers key advantages:

  • Home-based care and reduced travel burden.
  • Continuity of education (especially for children).
  • Greater treatment flexibility and continuity in fragile settings.
  • Potential to reduce the overall cost of treatment when scaled strategically.

Global Best Practices and Sustainability Framework

The advocacy paper cites international examples where “PD-first” policies have successfully expanded access:

  • PD-First Nations: Countries like Thailand, Hong Kong, and Mexico have implemented PD-first policies, increasing equitable access. Hong Kong, for instance, has successfully implemented a PD-first policy since 1985.
  • Active Promotion: Nations including the UK, Australia, and New Zealand actively promote PD as a preferred treatment choice.

To assess the feasibility in India’s resource-constrained setting, the researchers employed the Program Sustainability Assessment Tool (PSAT) Framework. PSAT, a globally recognized approach, identified the following as critical for success:

  • Political Support
  • Funding Stability
  • Strong Partnerships
  • Trained Health Workforce
  • Ongoing Evaluation

Policy Recommendations for Implementation

The experts propose clear, actionable steps to transition to equitable, home-based kidney care:

  1. PM-JAY Inclusion: Mandate the inclusion of comprehensive PD packages under the Pradhan Mantri Jan Arogya Yojana (PM-JAY), covering consumables, patient training, and essential telehealth support.
  2. State-Level Strategy: Develop specific State-level PD blueprints tailored to regional needs and resources.
  3. National PD Registry: Establish a national PD registry with equity-focused monitoring and transparent reporting to track access and outcomes.
  4. Partnerships and Education: Institute structured public-private partnerships and launch community-level education campaigns to improve PD acceptance and sustainability.
  5. Financial Protection: Ensure families are not burdened with catastrophic costs due to insurance exclusions for home-based care.

The foundation is set, with National Guidelines for implementing the PD program already developed. The key remaining step is the political will and inclusion of PD packages within the PM-JAY framework.

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar
Next: Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

Related Stories

Pharmup 1
2 min read
  • Pharma News

SIMATS and IPA Host Successful Five-Day Virtual Poster Showcase (VPS 2026)

Pharm'Up
Pharmup 2
1 min read
  • Pharma News

Amgen Reports Successful Phase 3 Results for TEPEZZA Subcutaneous Delivery in Thyroid Eye Disease

Pharm'Up
Pharmup 1
1 min read
  • Pharma News

FDA Clears Path for First Generic Versions of Diabetes and Heart Failure Drug Farxiga

Pharm'Up

Recent Posts

  • Understanding Small Intestine Cancer: Risks, Symptoms, and Treatment
  • Infant Reflux (GER) and GERD: Spitting Up and Growth
  • Understanding Reflux (GER) and GERD in Children
  • Gastroenteritis: Understanding the “Stomach Bug” and Food Poisoning
  • Stomach Health: Understanding Function and Common Disorders

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Understanding Small Intestine Cancer: Risks, Symptoms, and Treatment

Pharm'Up
Pharmup 20
2 min read
  • Disease

Infant Reflux (GER) and GERD: Spitting Up and Growth

Pharm'Up
Pharmup 19
2 min read
  • Disease

Understanding Reflux (GER) and GERD in Children

Pharm'Up
Pharmup 18
2 min read
  • Disease

Gastroenteritis: Understanding the “Stomach Bug” and Food Poisoning

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.